SENSEX NIFTY

Ranbaxy Laboratories

Mar 03, 2015 at 16:49 | Source: PTI
The DC Federal Court in the US has upheld the decision of the USFDA for rescinding tentative approvals given to it for generic digestive disorder drug Nexium and antiviral Valcyte.
Mar 03, 2015 at 08:33 | Source: CNBC-TV18
Sun Pharma | Bajaj Auto | Edelweiss | GMR Infrastructure | Bharti Airtel | Gayatri Project | Future Retail | Shree Cements | Sunstar Realty | Jubilant Life | TVS Motor | Hero Motocorp | Adani Power | Hindalco | Jindal Steel | Sesa Sterlite | Ranbaxy Labs | Coal India | Hotel Leela and Godrej Consumer are stocks, which are in the news today.
Feb 18, 2015 at 14:54 | Source: CNBC-TV18
The company has grown faster than the market in India and would be focused on research and development (R&D) spends going forward, said Uday Baldota, CFO, Sun Pharma.
Feb 13, 2015 at 14:46 | Source: Moneycontrol.com
Sun Pharmaceutical Industries will announce its third quarter earnings on Saturday. According to a CNBC-TV18 poll, net profit of the drug maker may rise 7 percent year-on-year to Rs 1,638 crore during October-December quarter, impacted by lower operating performance.
Feb 11, 2015 at 17:24 | Source: CNBC-TV18
Neeraj Deewan of Quantum Securities prefers Sun Pharmaceutical Industries.
Feb 05, 2015 at 09:51 | Source: CNBC-TV18
Watch the interview of VK Sharma, HDFC Securities with Latha Venkatesh & Sonia Shenoy on CNBC-TV18, in which he shared his readings and outlook on Futures and Options (F&O) side of the market, specific stocks and sectors.
Feb 05, 2015 at 09:47 | Source: CNBC-TV18
VK Sharma of HDFC Securities is of the view that one may buy Lupin 1600 Call and Ranbaxy Labs 740 Call.
Feb 02, 2015 at 15:11 | Source: CNBC-TV18
Meghana V Malkan of malkansview.com is of the view that one may buy Ranbaxy Laboratories and Apollo Tyres.
Feb 02, 2015 at 14:39 | Source: CNBC-TV18
CNBC-TV18's Sonia Shenoy lists out stocks that you should focus on.
Feb 02, 2015 at 10:57 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com advises buying Sun Pharmaceutical Industries.
Messages on Ranbaxy Laboratories »

Market Statistician

Platinum Member

12267 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 15:14 hrs, the share was quoting at Rs 545.65, up Rs 2.50, or 0.46%. See more

3.15 PM Jul 8th 2014

Market Statistician

Platinum Member

12267 Followers

Ranbaxy Labs  

At 15:14 hrs, Ranbaxy Laboratories was trading at Rs 545.65 up 0.46%, with a huge increase in its volume of shares traded. Till now over 220,541 shares were traded as compared to its 5-day average of 106,981 shares.

3.15 PM Jul 8th 2014

Market Statistician

Platinum Member

12267 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 14:14 hrs, the share was quoting at Rs 550.20, up Rs 7.05, or 1.30%. See more

2.15 PM Jul 8th 2014

Market Statistician

Platinum Member

12267 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 13:14 hrs, the share was quoting at Rs 552.10, up Rs 8.95, or 1.65%. See more

1.15 PM Jul 8th 2014

Market Statistician

Platinum Member

12267 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 12:14 hrs, the share was quoting at Rs 550.65, up Rs 7.50, or 1.38%. See more

12.15 PM Jul 8th 2014

Market Statistician

Platinum Member

12267 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 11:14 hrs, the share was quoting at Rs 552.35, up Rs 9.20, or 1.69%. See more

11.15 AM Jul 8th 2014

Market Statistician

Platinum Member

12267 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 538.45. At 15:14 hrs, the share was quoting at Rs 533.20, down Rs 0.10, or 0.02%. See more

3.15 PM Jul 4th 2014

Market Statistician

Platinum Member

12267 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 538.45. At 14:14 hrs, the share was quoting at Rs 532.20, down Rs 1.10, or 0.21%. See more

2.15 PM Jul 4th 2014

Market Statistician

Platinum Member

12267 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 538.45. At 13:13 hrs, the share was quoting at Rs 531.20, down Rs 2.10, or 0.39%. See more

1.15 PM Jul 4th 2014

Market Statistician

Platinum Member

12267 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 538.45. At 12:14 hrs, the share was quoting at Rs 532.15, down Rs 1.15, or 0.22%. See more

12.15 PM Jul 4th 2014

News across the web »
Feb 14, 2015 at 21:30 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.